Artesunate is ineffective in controlling valganciclovir-resistant cytomegalovirus infection

Clinical Infectious Diseases

Volumn 52, Issue 2, 2011, Pages 279-

  Lau, Peter Kar Han ^a   Woods, Marion L ^a   Ratanjee, Sharad Kanneyalal ^a   John, George Tharayil ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CIDOFOVIR; DILTIAZEM; ESOMEPRAZOLE; EVEROLIMUS; FENOFIBRATE; FOSCARNET; GANCICLOVIR; MYCOPHENOLIC ACID; PRAVASTATIN; PREDNISOLONE; SERTRALINE; TRANDOLAPRIL; VALGANCICLOVIR;

ALLOGRAFT; ANTIVIRAL SUSCEPTIBILITY; COLITIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; GASTRITIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LETTER; NEPHROTOXICITY; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINITIS; TREATMENT RESPONSE; VIRUS LOAD;

ANTIVIRAL AGENTS; ARTEMISININS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; GANCICLOVIR; HUMANS; TREATMENT FAILURE;

EID: 79951821212     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq050     Document Type: Letter

References (2)

1. Schreiber Andreas, Härter Georg, Schubert Axel, Bunjes Donald, Mertens Thomas, Michel Detlef. Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother 2009;10:191-209.
2. Michael Shapira Y, IgorResnick B, Chou Sunwen, et al. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis 2008;46:1455-1457.